Lynch & Associates Pfizer Inc Transaction History

Lynch & Associates

$467 Million
Q3 2024

A detailed history of Lynch & Associates transactions in Pfizer Inc stock. As of the latest transaction made, Lynch & Associates holds 93,557 shares of PFE stock, worth $2.35 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

93,557

Previous 97,182 3.73%

Holding current value

$2.35 Million

Previous $2.72 Million 0.44%

% of portfolio

0.58%

Previous 0.62%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$27.7 - $31.39 $100,412 - $113,788	-3,625 Reduced 3.73%	93,557 $2.71 Million
Q2 2024 Aug 06, 2024	BUY	$25.26 - $29.6 $180,634 - $211,669	7,151 Added 7.94%	97,182 $2.72 Million
Q1 2024 Apr 09, 2024	SELL	$25.89 - $29.73 $915,548 - $1.05 Million	-35,363 Reduced 28.2%	90,031 $2.5 Million
Q4 2023 Jan 08, 2024	SELL	$26.13 - $33.94 $799,682 - $1.04 Million	-30,604 Reduced 19.62%	125,394 $3.61 Million
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $1.21 Million - $1.41 Million	-37,683 Reduced 19.46%	155,998 $5.17 Million
Q2 2023 Oct 24, 2023	SELL	$36.12 - $41.79 $173,520 - $200,759	-4,804 Reduced 2.42%	193,681 $7.1 Million
Q2 2023 Jul 13, 2023	SELL	$36.12 - $41.79 $173,303 - $200,508	-4,798 Reduced 2.42%	193,681 $7.1 Million
Q1 2023 Oct 24, 2023	BUY	$39.39 - $51.28 $189,229 - $246,349	4,804 Added 2.48%	198,485 $8.1 Million
Q1 2023 Apr 04, 2023	SELL	$39.39 - $51.28 $275,296 - $358,395	-6,989 Reduced 3.4%	198,479 $8.1 Million
Q4 2022 Oct 24, 2023	BUY	$41.75 - $54.5 $2.07 Million - $2.7 Million	49,474 Added 31.71%	205,472 $10.5 Million
Q4 2022 Jan 05, 2023	BUY	$41.75 - $54.5 $3,548 - $4,632	85 Added 0.04%	205,468 $10.5 Million
Q3 2022 Oct 03, 2022	SELL	$43.76 - $53.42 $111,281 - $135,847	-2,543 Reduced 1.22%	205,383 $8.99 Million
Q2 2022 Jul 06, 2022	SELL	$46.53 - $55.17 $51,276 - $60,797	-1,102 Reduced 0.53%	207,926 $10.9 Million
Q1 2022 Apr 08, 2022	SELL	$45.75 - $56.69 $298,244 - $369,562	-6,519 Reduced 3.02%	209,028 $10.8 Million
Q4 2021 Jan 11, 2022	BUY	$41.32 - $61.25 $75,409 - $111,781	1,825 Added 0.85%	215,547 $12.7 Million
Q3 2021 Oct 12, 2021	BUY	$39.25 - $50.42 $104,915 - $134,772	2,673 Added 1.27%	213,722 $9.19 Million
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $80,187 - $90,838	2,233 Added 1.07%	211,049 $8.27 Million
Q1 2021 Apr 09, 2021	BUY	$33.49 - $37.77 $140,959 - $158,973	4,209 Added 2.06%	208,816 $7.57 Million
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $174,646 - $222,078	5,218 Added 2.62%	204,607 $7.53 Million
Q3 2020 Oct 21, 2020	BUY	$31.75 - $37.25 $18,732 - $21,977	590 Added 0.3%	199,389 $7.32 Million
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $120,751 - $146,488	-4,009 Reduced 1.98%	198,799 $6.5 Million
Q1 2020 Apr 28, 2020	BUY	$27.03 - $38.62 $82,819 - $118,331	3,064 Added 1.53%	202,808 $6.62 Million
Q4 2019 Jan 10, 2020	SELL	$32.92 - $37.36 $116,043 - $131,694	-3,525 Reduced 1.73%	199,744 $7.83 Million
Q3 2019 Oct 03, 2019	BUY	$32.49 - $42.13 $27,161 - $35,220	836 Added 0.41%	203,269 $7.3 Million
Q2 2019 Jul 19, 2019	BUY	$36.98 - $41.52 $71,334 - $80,092	1,929 Added 0.96%	202,433 $8.77 Million
Q1 2019 Apr 25, 2019	BUY	$37.5 - $41.2 $69,750 - $76,632	1,860 Added 0.94%	200,504 $8.52 Million
Q4 2018 Jan 10, 2019	SELL	$38.47 - $43.86 $884 - $1,008	-23 Reduced 0.01%	198,644 $8.67 Million
Q3 2018 Oct 05, 2018	SELL	$34.47 - $41.81 $142,188 - $172,466	-4,125 Reduced 2.03%	198,667 $8.76 Million
Q2 2018 Jul 09, 2018	BUY	$32.98 - $35.16 $375,345 - $400,155	11,381 Added 5.95%	202,792 $7.36 Million
Q1 2018 Apr 06, 2018	BUY	$31.91 - $37.02 $200,490 - $232,596	6,283 Added 3.39%	191,411 $6.79 Million
Q4 2017 Jan 04, 2018	BUY	$33.26 - $35.29 $103,904 - $110,245	3,124 Added 1.72%	185,128 $6.71 Million
Q3 2017 Oct 18, 2017	BUY	$31.0 - $34.15 $5.64 Million - $6.22 Million	182,004	182,004 $6.5 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Lynch & Associates with notifications on news.

Account

Lynch & Associates Pfizer Inc Transaction History